tiprankstipranks
Argenica Therapeutics Ltd (AU:AGN)
:AGN
Australian Market

Argenica Therapeutics Ltd (AGN) Income Statement

Compare
10 Followers

Argenica Therapeutics Ltd Income Statement

Last quarter (Q4 2024), Argenica Therapeutics Ltd's total revenue was AU$122.76K, a decrease of -34.00% from the same quarter last year. In Q4, Argenica Therapeutics Ltd's net income was AU$-2.03M. See Argenica Therapeutics Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07KAU$ 0.00
Gross Profit
AU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07KAU$ 0.00
Operating Expenses
AU$ 8.27MAU$ 6.62MAU$ 4.35MAU$ 1.33MAU$ 383.65K
Depreciation and Amortization
AU$ 5.67MAU$ 4.87MAU$ 4.09MAU$ 1.03MAU$ 657.69K
EBITDA
AU$ -1.90MAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Operating Income
AU$ -5.67MAU$ -6.62MAU$ -4.09MAU$ -1.03MAU$ -383.65K
Other Income/Expenses
AU$ -1.90MAU$ 431.93KAU$ 1.68KAU$ 182.00AU$ 247.00
Pretax Income
AU$ -7.57MAU$ -6.19MAU$ -4.09MAU$ -1.03MAU$ -383.40K
Net Income
AU$ -5.48MAU$ -4.82MAU$ -4.09MAU$ -1.03MAU$ -383.40K
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.05AU$ -0.06AU$ -0.06AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.05AU$ -0.06AU$ -0.06AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
103.39M 87.58M 73.93M 73.17M 73.17M
Weighted Average Shares Outstanding (Diluted)
103.71M 87.58M 73.93M 73.17M 73.17M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis